Of the 13 BC smoking-dysregulated genes localized to 19q13.2, four, NFKBIB, LTBP4, EGLN2 and TGFB1, have been implicated by GWAS and/or candidate gene studies to be a risk for developing COPD. This evidence concerns the gene EGLN2 and chronic obstructive pulmonary disease.